Ishiga K - Search Results

1

Serum soluble IL-6 receptor levels during the mobilization of stem cells to peripheral blood.

Omura H, Kawatani T, Tajima F, Ishiga K, Ohmura H, Kawasaki H, Nanba E. Omura H, et al. Among authors: ishiga k. Leuk Lymphoma. 2002 Mar;43(3):623-30. doi: 10.1080/10428190290012164. Leuk Lymphoma. 2002. PMID: 12002769 Clinical Trial.

2

Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.

Nakamura Y, Tajima F, Ishiga K, Yamazaki H, Oshimura M, Shiota G, Murawaki Y. Nakamura Y, et al. Among authors: ishiga k. Exp Hematol. 2004 Apr;32(4):390-6. doi: 10.1016/j.exphem.2004.01.004. Exp Hematol. 2004. PMID: 15050750 Free article.

3

Serum soluble c-kit receptor and expression of c-kit protein and mRNA in acute myeloid leukemia.

Tajima F, Kawatani T, Ishiga K, Nanba E, Kawasaki H. Tajima F, et al. Among authors: ishiga k. Eur J Haematol. 1998 May;60(5):289-96. doi: 10.1111/j.1600-0609.1998.tb01042.x. Eur J Haematol. 1998. PMID: 9654158

4

Serum-soluble c-kit levels during mobilization of peripheral blood stem cells correlate with stem cell yield.

Ishiga K, Kawatani T, Tajima F, Omura H, Nanba E, Kawasaki H. Ishiga K, et al. Int J Hematol. 2000 Aug;72(2):186-93. Int J Hematol. 2000. PMID: 11039667

5

Primary effusion lymphoma of the left scrotum.

Nakamura Y, Tajima F, Omura H, Ishiga K, Kawatani T, Murawaki Y. Nakamura Y, et al. Among authors: ishiga k. Intern Med. 2003 Apr;42(4):351-3. doi: 10.2169/internalmedicine.42.351. Intern Med. 2003. PMID: 12729325 Free article.

6

Liver dysfunction in patients with acute myelogenous leukemia: studies on patients not infected with hepatitis C virus during intense therapy.

Kawatani T, Tajima F, Ishiga K, Suou T, Kawasaki H. Kawatani T, et al. Among authors: ishiga k. J Med. 1998;29(1-2):45-56. J Med. 1998. PMID: 9704292

7

Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia.

Ishiga K, Kawatani T, Suou T, Tajima F, Omura H, Idobe Y, Kawasaki H. Ishiga K, et al. Int J Hematol. 2001 Jan;73(1):115-8. doi: 10.1007/BF02981912. Int J Hematol. 2001. PMID: 11372746

8

Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.

Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, Ohmura H, Ikuta Y, Idobe Y, Kawasaki H. Kawatani T, et al. Among authors: ishiga k. Eur J Haematol. 2001 Jul;67(1):45-50. doi: 10.1034/j.1600-0609.2001.067001045.x. Eur J Haematol. 2001. PMID: 11553266

9

Effect of Interferon-α on Patients with Previously Untreated Chronic Myelogenous Leukemia in the Early Chronic Phase: Comparison between Interferon-α Continued Patients and Interferon-α Discontinued Patients.

Kawatani T, Tajima F, Ishiga K, Omura H, Endo A, Ago H, Ohi S, Kawasaki H. Kawatani T, et al. Among authors: ishiga k. Hematology. 2001;5(6):429-34. doi: 10.1080/10245332.2001.11746539. Hematology. 2001. PMID: 27419345 Free article.

10

Myasthenia gravis with thymus hyperplasia and pure red cell aplasia.

Suto Y, Araga S, Sakuma K, Nakano T, Ishiga K, Tajima F, Kowa H, Nakashima K. Suto Y, et al. Among authors: ishiga k. J Neurol Sci. 2004 Sep 15;224(1-2):93-5. doi: 10.1016/j.jns.2004.06.003. J Neurol Sci. 2004. PMID: 15450777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters